PROBLEM TO BE SOLVED: To provide a neovascularization inhibitor which uses a new ingredient as an active ingredient.SOLUTION: The characteristics of this invention are as follows: a neovascularization inhibitor (1) using the extract of black rice as an active ingredient a neovascularization inhibitor (2) using cyanidin and/or a cyanidin glycoside as an active ingredient a neovascularization inhibitor (3) using peonidin and/or a peonidin glycoside as an active ingredient a retinal degenerative disease preventing agent (4) using the agent mentioned in any one paragraph from the inhibitor (1) to (3) as an active ingredient the retinal degenerative disease preventing agent (5) mentioned in the retinal degenerative disease preventing agent (4) in which the retinal degenerative disease is retinitis pigmentosa, cone dystrophy, diabetic retinopathy, age-related macular degeneration, age-related maculopathy, macula edema, retinal detachment, cancer-related retinopathy, retinal vein occlusion or detachment of retinal pigment epithelium and a cancer preventing-treating agent (6) using the agent mentioned in any one paragraph from the inhibitor (1) to (3) as an active ingredient.COPYRIGHT: (C)2012,JPO&INPIT【課題】 新規の成分を有効成分とする血管新生抑制剤を提供すること【解決手段】上記課題を解決するための本発明の特徴は以下の通りである。1.黒米の抽出物を有効成分とする血管新生抑制剤。2.シアニジン及び/又はシアニジン配糖体を有効成分とする血管新生抑制剤。3.ペオニジン及び/又はペオニジン配糖体を有効成分とする血管新生抑制剤。4.上記1.乃至上記3.の何れか1項に記載の剤を有効成分とする網膜変性疾患予防剤。5.前記網膜変性疾患は、網膜色素変性、錐体ジストロフィー、糖尿病網膜症、加齢黄斑変性、加齢黄斑症、黄斑浮腫、網膜剥離、癌関連網膜症、網膜静脈閉塞症または網膜色素上皮剥離である上記4.に記載の網膜変性疾患予防剤。6.上記1.乃至上記3.の何れか1項に記載の剤を有効成分とする癌予防・治療剤。【選択図】なし
